The Medical Advisor

Contents: Introduction Lymphoma Case Series (23 case reports) Leukemia Case Series (10 case reports) Discussion Conclusion Introduction Drug repurposing sits at the intersection of curiosity and caution. Ivermectin and mebendazole — long-used antiparasitic medications — have accumulated a growing body of laboratory evidence suggesting anticancer activity across multiple pathways. Meanwhile, a series of 29 reported cases involving lymphoma and leukemia patients describe tumor regression, remission, or hematologic normalization after incorporating these agents into their regimens. The central question is not whether these reports “prove” efficacy. The more relevant question is whether they represent noise, coincidence, or early translational signals that warrant structured investigation. Lymphoma Success Stories (23 cases) Case 24 (2026): Aggressive Hodgkin’s lymphoma, failed chemo and failed an autologous bone marrow transplant @PerilousPeg posted on  X.com  in April 2026:...